New single institution study suggests HIGHER rates of BRCA1/2 mutations in Hispanic women with breast cancer. Specifically, a study of 2401 unselected breast cancer patients showed that Hispanic women were more than 2.5 times more likely to have a BRCA1/2 mutation compared to non-Hispanic women. BRCA1/2 mutations were found in: These findings show the importance …
Permanent link to this article: https://inheritedcancer.net/post-10212025/
A recent study found that non-Hispanic Black and Hispanic women are underrepresented in clinical trials evaluating PARP inhibitor use among ovarian cancer patients; therefore, these trials do not accurately represent the ovarian cancer patient population. These findings indicate initiatives to increase diversity in clinical trials are needed. Read the full article for more information 👇https://www.gynecologiconcology-online.net/article/S0090-8258(22)00071-3/fulltext#secst0030Reference: …
Permanent link to this article: https://inheritedcancer.net/post42222/
